OS Therapies Incorporated (OSTX)

OS Therapies Statistics

Total Valuation

OS Therapies has a market cap or net worth of $55.49 million. The enterprise value is $72.09 million.

Market Cap	55.49M
Enterprise Value	72.09M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

OS Therapies has 20.88 million shares outstanding. The number of shares has increased by 8.92% in one year.

Shares Outstanding	20.88M
Shares Change (YoY)	+8.92%
Shares Change (QoQ)	-47.49%
Owned by Insiders (%)	17.82%
Owned by Institutions (%)	0.54%
Float	16.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	362.68
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.05

Current Ratio	0.05
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.98

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.64M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.38
200-Day Moving Average	n/a
Relative Strength Index (RSI)	34.02
Average Volume (20 Days)	25,859

Short Selling Information

The latest short interest is 8,931, so 0.04% of the outstanding shares have been sold short.

Short Interest	8,931
Short Previous Month	n/a
Short % of Shares Out	0.04%
Short % of Float	0.05%
Short Ratio (days to cover)	0.01

Income Statement

Revenue	n/a
Gross Profit	-5,154
Operating Income	-3.19M
Pretax Income	n/a
Net Income	-6.55M
EBITDA	-3.18M
EBIT	-3.19M
Earnings Per Share (EPS)	-$0.60

Balance Sheet

The company has $94,925 in cash and $16.70 million in debt, giving a net cash position of -$16.60 million or -$0.80 per share.

Cash & Cash Equivalents	94,925
Total Debt	16.70M
Net Cash	-16.60M
Net Cash Per Share	-$0.80
Equity (Book Value)	-27.06M
Book Value Per Share	-4.52
Working Capital	-26.97M

Cash Flow

In the last 12 months, operating cash flow was -$3.27 million and capital expenditures $19, giving a free cash flow of -$3.27 million.

Operating Cash Flow	-3.27M
Capital Expenditures	19
Free Cash Flow	-3.27M
FCF Per Share	-$0.16

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OS Therapies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.92%
Shareholder Yield	-8.92%
Earnings Yield	-11.80%
FCF Yield	-5.89%

Analyst Forecast

The average price target for OS Therapies is $21.00, which is 690.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	690.37%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1